Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beyer

Showing results (501-510 of 516) with videos related to

Pageof 52
Sort By:
Hypertension (Dallas, Tex. : 1979)|November 27, 2024
UBR1 Promotes Sex-Dependent ACE2 Ubiquitination in HypertensionMona Elgazzaz, Navya Lakkappa, Clara Berdasco, et al.
Journal of Medicinal Chemistry|January 2, 2010
Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitorsYu-Sen Wang, Corey Strickland, Johannes H Voigt, et al.
Cancer|April 15, 2025
Contemporary neighborhood redlining and racial mortgage lending bias and disparities in prostate cancer survivalWayne R Lawrence, Neal D Freedman, Jennifer K McGee-Avila, et al.
Medrxiv : the Preprint Server for Health Sciences|June 3, 2024
UBR1 Promotes Sex-Dependent ACE2 Ubiquitination in HypertensionMona Elgazzaz, Navya Lakkappa, Clara Berdasco, et al.
Hypertension (Dallas, Tex. : 1979)|June 14, 2021
Dietary Sodium Restriction Results in Tissue-Specific Changes in DNA Methylation in HumansSrividya Kidambi, Xiaoqing Pan, Chun Yang, et al.
Journal of Medicinal Chemistry|January 7, 2005
Dual angiotensin II and endothelin A receptor antagonists: synthesis of 2'-substituted N-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokineticsNatesan Murugesan, Zhengxiang Gu, Leena Fadnis, et al.
European Heart Journal|July 14, 2020
Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophyJanika Viereck, Anne Bührke, Ariana Foinquinos, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: synthesis and characterization of analogs with a fused 5,6-bicyclic ring motifA Chris Krueger, John T Randolph, David A DeGoey, et al.
Journal of Medicinal Chemistry|August 23, 2002
Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonistsNatesan Murugesan, John E Tellew, Zhengxiang Gu, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate CancerAudris Huang, Lata Jayaraman, Aberra Fura, et al.
Pageof 52

Showing results (501-510 of 516) with videos related to

Sort By:
Pageof 52
Hypertension (Dallas, Tex. : 1979)|November 27, 2024
UBR1 Promotes Sex-Dependent ACE2 Ubiquitination in HypertensionMona Elgazzaz, Navya Lakkappa, Clara Berdasco, et al.
Journal of Medicinal Chemistry|January 2, 2010
Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitorsYu-Sen Wang, Corey Strickland, Johannes H Voigt, et al.
Cancer|April 15, 2025
Contemporary neighborhood redlining and racial mortgage lending bias and disparities in prostate cancer survivalWayne R Lawrence, Neal D Freedman, Jennifer K McGee-Avila, et al.
Medrxiv : the Preprint Server for Health Sciences|June 3, 2024
UBR1 Promotes Sex-Dependent ACE2 Ubiquitination in HypertensionMona Elgazzaz, Navya Lakkappa, Clara Berdasco, et al.
Hypertension (Dallas, Tex. : 1979)|June 14, 2021
Dietary Sodium Restriction Results in Tissue-Specific Changes in DNA Methylation in HumansSrividya Kidambi, Xiaoqing Pan, Chun Yang, et al.
Journal of Medicinal Chemistry|January 7, 2005
Dual angiotensin II and endothelin A receptor antagonists: synthesis of 2'-substituted N-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokineticsNatesan Murugesan, Zhengxiang Gu, Leena Fadnis, et al.
European Heart Journal|July 14, 2020
Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophyJanika Viereck, Anne Bührke, Ariana Foinquinos, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2013
Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: synthesis and characterization of analogs with a fused 5,6-bicyclic ring motifA Chris Krueger, John T Randolph, David A DeGoey, et al.
Journal of Medicinal Chemistry|August 23, 2002
Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonistsNatesan Murugesan, John E Tellew, Zhengxiang Gu, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate CancerAudris Huang, Lata Jayaraman, Aberra Fura, et al.
Pageof 52